Gameto is a female-led biotech company developing treatment solutions to improve women's reproductive health throughout their lives: from egg freezing, infertility, and diseases of the reproductive years to menopause and conditions that occur afterward.
We are building treatment solutions to provide better options for women.
Women's reproductive health is an underdeveloped area within the healthcare industry.
Despite a growing global infertility crisis, female reproductive therapies have remained largely unimproved since inception decades ago.
Until now.
We’ve developed a platform that is broadly applicable and has the potential to solve many gaps in the women’s health space. Our first focus is filling the massive gaps in the fertility space.
Creating transformative solutions for women’s health
The first application of our technology aims to improve the current IVF and egg freezing landscape. We are advancing technology in a space that has been virtually untouched since inception.
Scientists, Innovators, and Biotechnology Entrepreneurs
Our female-led team understands the burden women take when embarking on their reproductive journeys and is passionate about improving it. Our mission to redefine women's health guides everything we do.
The next frontier in baby-making: More successful IVF, egg cells from men, and sperm cells from women? Biotech researchers aim to greatly expand reproductive opportunity.
Read article
News
Gameto Unveils New Data on In Vitro Maturation Product Candidate Fertilo During Four Presentations at the 2023 American Society for Reproductive Medicine
Read article
News
Gameto CEO Dr. Dina Radenkovic Recognized Among the Most Exceptional Entrepreneurs at the Goldman Sachs 2023 Builders and Innovators Summit
Read article
News
This biotech CEO decided to take her own (fertility) medicine
Read article
News
Gameto inks stem cell deal with Reprocell for female fertility program
Read article
REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs
Read article
News
What if We Could Get Rid of Menopause?
Read article
News
Gameto Named as 2023 Technology Pioneer by World Economic Forum
Read article
News
The Future of Fertility: A new crop of biotech startups want to revolutionize human reproduction.
Read article
News
Fertility treatments, closer to becoming cheaper?
Read article
News
This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF
Read article
News
Reimagining Infertility – An Interview with Christian Kramme
Read article
News
Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University
Read article
News
Why it is key to anticipate to preserve fertility?
Read article
News
A healthcare brand for women begins to take shape
Read article
News
Forbes Under 30 Healthcare 2023: Fighting Cancer, Expanding Access To Care And Protecting Women's Health
Read article
News
Inception Fertility Partners with Leading Technology Companies on Breakthrough Studies to Advance Reproductive Medicine
Read article
News
34 of the most promising women's health startups of 2022, according to VCs
Read article
News
Gameto, the biotech startup that uses cell engineering to treat with ovarian deterioration, arrives in Spain
Read article
News
Varsavsky chooses Madrid for the preclinical studies in Europe of his startup Gameto
Read article
News
Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics
Read article
News
Biotech Startup Gameto on Female Fertility and Aging
Read article
News
Gameto, the startup that seeks to delay menopause, lands in Spain
Read article
News
Is it Time to Cancel Menopause?
Read article
News
The 20(+1) under 40: Your guide to the next generation of biotech leaders
Read article
News
Why aren’t VCs funding more startups focused on menopause?
Read article
News
International Women’s Day: the wonderful women of longevity
Read article
News
Gameto founder talks menopause and female healthspan extension
Read article
News
Nature Is Sexist. Can Advances In Longevity Biotechnology Help Restore Reproductive Equality?
Read article
News
Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells
Read article
Scientific Publications
An integrated pipeline for mammalian genetic screening